dr. (Amir) A Omidvari

Researcher

Email: a.omidvari@erasmusmc.nl

Rotterdam School of Management, Erasmus University

Lecturer | Department of Technology and Operations Management

Email: a.omidvari@rsm.nl
Room: T09-36
Location: Burg. Oudlaan 50, Rotterdam

Pure profile

Work

Brechtje D.M. Koopmann, Amir Houshang Omidvari, Iris Lansdorp-Vogelaar, Djuna L. Cahen, Marco J. Bruno & Inge M.C.M. de Kok (2023) - The impact of pancreatic cancer screening on life expectancy: A systematic review of modeling studies - International Journal of Cancer, 152 (8), 1570-1580 - doi: 10.1002/ijc.34379 - [link]
Skander Tahar Mulder, Amir Houshang Omidvari, Anja J. Rueten-Budde, Pei Hua Huang, Ki Hun Kim, Babette Bais, Melek Rousian, Rihan Hai, Can Akgun, Jeanine Roeters van Lennep, Sten Willemsen, Peter R. Rijnbeek, David Mj Tax, Marcel Reinders, Eric Boersma, Dimitris Rizopoulos, Valentijn Visch & Régine Steegers-Theunissen (2022) - Dynamic Digital Twin: Diagnosis, Treatment, Prediction, and Prevention of Disease During the Life Course - Journal of Medical Internet Research, 24 (9) - doi: 10.2196/35675 - [link]
Joel H. Rubenstein, Amir Houshang Omidvari, Brianna N. Lauren, William D. Hazelton, Francesca Lim, Sarah Xinhui Tan, Chung Yin Kong, Minyi Lee, Ayman Ali, Chin Hur, John M. Inadomi, Georg Luebeck & Iris Lansdorp-Vogelaar (2022) - Endoscopic Screening Program for Control of Esophageal Adenocarcinoma in Varied Populations: A Comparative Cost-Effectiveness Analysis - Gastroenterology, 163 (1), 163-173 - doi: 10.1053/j.gastro.2022.03.037 - [link]
Amir Houshang Omidvari, Iris Lansdorp-Vogelaar & Joel H. Rubenstein (2022) - Reply - Gastroenterology, 162 (1), 351-352 - doi: 10.1053/j.gastro.2021.09.056 - [link]
Amir Houshang Omidvari, Iris Lansdorp-Vogelaar, Harry J. de Koning & Reinier G.S. Meester (2021) - Impact of assumptions on future costs, disutility and mortality in cost-effectiveness analysis; a model exploration - PLoS ONE, 16 (7 July) - doi: 10.1371/journal.pone.0253893 - [link]
Amir Houshang Omidvari, William D. Hazelton, Brianna N. Lauren, Steffie K. Naber, Minyi Lee, Ayman Ali, Claudia Seguin, Chun Yin Kong, Ellen Richmond, Joel H. Rubenstein, Georg E. Luebeck, John M. Inadomi, Chin Hur & Iris Lansdorp-Vogelaar (2021) - The Optimal Age to Stop Endoscopic Surveillance of Patients With Barrett's Esophagus Based on Sex and Comorbidity: A Comparative Cost-Effectiveness Analysis - Gastroenterology, 161 (2), 487-494 - doi: 10.1053/j.gastro.2021.05.003 - [link]
Elisabeth F.P. Peterse, Reinier G.S. Meester, Lucie De Jonge, Amir Houshang Omidvari, Fernando Alarid-Escudero, Amy B. Knudsen, Ann G. Zauber & Iris Lansdorp-Vogelaar (2021) - Comparing the Cost-Effectiveness of Innovative Colorectal Cancer Screening Tests - Journal of the National Cancer Institute, 113 (2), 154-161 - doi: 10.1093/jnci/djaa103 - [link]
Amir Omidvari (2020) - Screening for and surveillance of Barrett’s esophagus: a cost-effectiveness assessment - [link]
Amir Omidvari, A Ali, WD Hazelton, Sonja Kroep, Max Lee, Steffie Naber, BN Lauren, S Ostvar, E Richmond, CY Kong, JH Rubenstein, Iris Lansdorp - Vogelaar, G Luebeck, C Hur & J Inadomi (2020) - Optimizing Management of Patients With Barrett's Esophagus and Low-Grade or No Dysplasia Based on Comparative Modeling - Clinical Gastroenterology and Hepatology, 18 (9), 1961-1969 - doi: 10.1016/j.cgh.2019.11.058 - [link]
Amir Omidvari, Carlijn Roumans, Steffie Naber, Sonja Kroep, Bas Wijnhoven, Ate van der Gaast, Pieter Jan de Jonge, Manon Spaander & Iris Lansdorp - Vogelaar (2020) - The Impact of the Policy-Practice Gap on Costs and Benefits of Barrett's Esophagus Management - American Journal of Gastroenterology, 115 (7), 1026-1035 - doi: 10.14309/ajg.0000000000000578 - [link]